I'm LydiaRamsey Pflanzer, and today in healthcare news.The 24 biotech startups VCs say will take off in the next year;Flawed ideas about testosterone are fueling Republican bills to ban trans kids in sports;Your COVID-19 vaccine isn't perfect.
Glenmark Life Sciences shares are likely to get listed on 6th August...Premium Premium Windlas Biotech, Krsnaa Diagnostics among 5 pharma IPOs .... Premium Premium Beauty startup Nykaa files DRHP to raise funds via IPO ... The listEmcure Pharma, Vijaya Diagnostic Centre, Krsnaa Diagnostics, Supriya Lifesciences and Windlass Biotech's ₹400 crore issue ... .
Real estate company Macrotech Developers, which operates under the ‘Lodha’ brand, reported muted operating performance in the June quarter ... MORE FROM THIS SECTIONSee All.Premium Premium RolexRingsIPO ... Premium Premium Windlas Biotech, Krsnaa Diagnostics among 5 pharma IPOs .... Premium Premium Beauty startup Nykaa files DRHP to raise funds via IPO ... .
The company's price band was fixed at ₹880-900 per share. RolexRingsIPO share allotment is expected to be finalized tomorrow i.e., August 4 ... MORE FROM THIS SECTIONSee All ... How t .... Premium Premium Windlas Biotech, Krsnaa Diagnostics among 5 pharma IPOs .... Premium Premium Beauty startup Nykaa files DRHP to raise funds via IPO ... MINT PREMIUM See All ... .
To date, BGN�Technologies�has established over 100 startup companies�in the fields of biotech, hi-tech, and cleantech, and has initiated leading technology hubs,�incubators, and accelerators.�Over the past decade, BGN Technologies has focused on creating long-term partnerships ...
Noom The 9 healthcare startups that took in the most cash as VCs made record bets on transforming pharmacies and biotech ... More stories we're reading.Pfizer and Moderna increased their vaccine prices in the EU (Financial Times)Telehealth startups just raked in a record $5 billion.
Seattle startup Nautilus Biotechnology is developing a device to identify and count 95% of the different types of proteins in a biological sample, a process that could lead the way to new treatments and medicines ... .
I published a deep dive into the promises and pitfalls of synthetic cannabinoids and the surprising amount of money being poured into research by startups ... Biotech startups are chasing what Wall Street analysts say could become a $115 billion market for synthetic cannabis compounds.
The deal stands to make Vacasa the most valuable new Oregon company in generations ... Rapid growth ... He still lives in the Portland area ... And earlier this month, Vancouver biotech startup Absci went public in an IPO that valued that business at roughly $2 billion. Wilsonville clean energy startup ESS Tech also plans to go public this fall ... ....
Portland vacation management giant Vacasa said Thursday it plans to go public in a deal with an investment fund that will value the business at $4.5 billion, instantly making Vacasa one of Oregon’s most valuable companies ... And earlier this month, Vancouver biotech startup Absci went public in an IPO that valued that business at roughly $2 billion ... .
The 9 behind-the-scenes players who can make or break your digital-health startup ... See the slide deck that helped Deep Genomics convince SoftBank and Khosla to bet on the AI-focused biotech startup.
We’ll also be talking about what it means to build a biotech startup with true platform potential, and how that might differ now as compared to what investors were looking for just a few short years ago ...JoinSecretary Buttigieg and over 10,000 of the startup world’s most influential people at Disrupt 2021 online this September 21-23.
A slew of launch startups have emerged in recent years to help meet growing demand from satellite providers, biotech companies and others looking to send payload to space. One such startup is Germany’s Isar Aerospace Technologies, which is focused on building orbital launch vehicles designed to carry up to 1,000 kilograms to low Earth orbit.